Dull TJ - Search Results

1

Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors.

Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Byrn RA, Finer MH. Roberts MR, et al. Among authors: dull tj. Blood. 1994 Nov 1;84(9):2878-89. Blood. 1994. PMID: 7949163 Free article.

2

kat: a high-efficiency retroviral transduction system for primary human T lymphocytes.

Finer MH, Dull TJ, Qin L, Farson D, Roberts MR. Finer MH, et al. Among authors: dull tj. Blood. 1994 Jan 1;83(1):43-50. Blood. 1994. PMID: 8274751 Free article.

3

Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.

Roberts MR, Cooke KS, Tran AC, Smith KA, Lin WY, Wang M, Dull TJ, Farson D, Zsebo KM, Finer MH. Roberts MR, et al. Among authors: dull tj. J Immunol. 1998 Jul 1;161(1):375-84. J Immunol. 1998. PMID: 9647246

4

Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.

Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568

5

A new-generation stable inducible packaging cell line for lentiviral vectors.

Farson D, Witt R, McGuinness R, Dull T, Kelly M, Song J, Radeke R, Bukovsky A, Consiglio A, Naldini L. Farson D, et al. Hum Gene Ther. 2001 May 20;12(8):981-97. doi: 10.1089/104303401750195935. Hum Gene Ther. 2001. PMID: 11387062

6

A third-generation lentivirus vector with a conditional packaging system.

Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. Dull T, et al. J Virol. 1998 Nov;72(11):8463-71. doi: 10.1128/JVI.72.11.8463-8471.1998. J Virol. 1998. PMID: 9765382 Free PMC article.

7

Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector.

Tsui LV, Kelly M, Zayek N, Rojas V, Ho K, Ge Y, Moskalenko M, Mondesire J, Davis J, Roey MV, Dull T, McArthur JG. Tsui LV, et al. Nat Biotechnol. 2002 Jan;20(1):53-7. doi: 10.1038/nbt0102-53. Nat Biotechnol. 2002. PMID: 11753362

8

Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.

Roesler J, Brenner S, Bukovsky AA, Whiting-Theobald N, Dull T, Kelly M, Civin CI, Malech HL. Roesler J, et al. Blood. 2002 Dec 15;100(13):4381-90. doi: 10.1182/blood-2001-12-0165. Epub 2002 Aug 1. Blood. 2002. PMID: 12393624 Free article.

9

Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. Zufferey R, et al. J Virol. 1998 Dec;72(12):9873-80. doi: 10.1128/JVI.72.12.9873-9880.1998. J Virol. 1998. PMID: 9811723 Free PMC article.

10

Human beta-nerve growth factor gene sequence highly homologous to that of mouse.

Ullrich A, Gray A, Berman C, Dull TJ. Ullrich A, et al. Among authors: dull tj. Nature. 1983 Jun 30;303(5920):821-5. doi: 10.1038/303821a0. Nature. 1983. PMID: 6688123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters